FY27-28 Pediatric Flu Vaccines
Closed Solicitation Posted
- Solicitation number
- 75D30126R73518
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Atlanta, Georgia 30329, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention seeks FDA-approved pediatric influenza vaccines for children aged 0–18 years under an Indefinite Delivery/Indefinite Quantity multiple-award contract, with proposals due September 16, 2026 at 1:00 PM EST. This is a WOSB set-aside.
Offerors must be manufacturers of pediatric vaccines as defined in 42 U.S.C. 1396s. Place of performance is delivery to CDC centralized distribution locations in Olive Branch, Mississippi and Clermont, Kentucky, with fall 2027 delivery timeline. Shelf life expiry for all products must be no earlier than June 30, 2028. The contract period runs December 31, 2026 through February 28, 2028, with a combined aggregate maximum ceiling of $850 million across all awarded contracts; individual contract maximums are to be determined by mutual agreement. The minimum order size is 100 doses per vaccine, with a maximum of 30 million doses per contract line item number. Pricing is firm-fixed-price, inclusive of Federal Excise Tax where applicable.
All products must comply with Current Good Manufacturing Practice Regulations (21 CFR Parts 210, 211). Contractors must interface with the CDC's Vaccine Tracking System (VTrckS) for electronic order placement and reporting, submit monthly biological surveillance sales data reports, and comply with Drug Supply Chain Security Act requirements. Contractors must agree to public disclosure of vaccine pricing, including per-dose pricing, product names, National Drug Codes, and contract numbers. Non-small business offerors with proposals exceeding $900,000 must submit acceptable subcontracting plans with CDC small business goals of 9.37% small business, 2.17% small disadvantaged business, 0.70% HUBZone, 1.44% women-owned small business, and 2.33% service-disabled veteran-owned small business. Contractors planning AI use during performance must submit an AI Compliance and Risk Management Plan. The NAICS code is 325412, Pharmaceutical Preparation Manufacturing; PSC is 6505, Drugs and Biologicals.
Notice text
2 versions
Update #2 · Latest ·
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds.
Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.
Update #1 ·
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds.
Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.
Files
| File | Type | Posted |
|---|---|---|
| A19 75D30126R73518 0001 FY27-28 Peditatric Flu Sol..docx | DOCX document | |
| A19 - 75D30126R73518 0001 1449 Solicitation Cover Page.pdf | ||
| A19 - 75D30126R73406 - 1449 Solicitation Cover Page 2021 version.pdf | ||
| A19 D-3 AI Use Compliance Risk Management Plan.docx | DOCX document | |
| A19 D-4 Public Disclosure and Publication of Vaccine Pricing.docx | DOCX document | |
| A19 75D30126R73518 FY27-28 Peditatric Flu Sol..docx | DOCX document | |
| A19 D-1 ADR Pediatric.docx | DOCX document | |
| A19 D-2 List of Products.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity